ArticleCardio-oncology (London, England)2021

Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia.

Lisa Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.